RT Journal Article
SR Electronic
T1 A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.15.21253625
DO 10.1101/2021.03.15.21253625
A1 Mohd A Karim
A1 Jarrod Shilts
A1 Jeremy Schwartzentruber
A1 James Hayhurst
A1 Annalisa Buniello
A1 Elmutaz Shaikho Elhaj Mohammed
A1 Jie Zheng
A1 Michael V Holmes
A1 David Ochoa
A1 Miguel Carmona
A1 Joseph Maranville
A1 Tom R. Gaunt
A1 Valur Emilsson
A1 Vilmundur Gudnason
A1 Ellen M. McDonagh
A1 Gavin J. Wright
A1 Maya Ghoussaini
A1 Ian Dunham
YR 2021
UL http://medrxiv.org/content/early/2021/03/17/2021.03.15.21253625.abstract
AB The virus SARS-CoV-2 can exploit biological vulnerabilities in susceptible hosts that predispose to development of severe COVID-19. Previous reports have identified several host proteins related to the interferon response (e.g. OAS1), interleukin-6 signalling (IL-6R), and the coagulation cascade (linked via ABO) that were associated with risk of COVID-19. In the present study, we performed proteome-wide genetic colocalisation tests leveraging publicly available protein and COVID-19 datasets, to identify additional proteins that may contribute to COVID-19 risk. Our analytic approach identified several known targets (e.g. ABO, OAS1), but also nominated new proteins such as soluble FAS (colocalisation probability > 0.9, p = 1 × 10−4), implicating FAS-mediated apoptosis as a potential target for COVID-19 risk. We also undertook polygenic (pan) and cis-Mendelian randomisation analyses that showed consistent associations of genetically predicted ABO protein with several COVID-19 phenotypes. The ABO signal was associated with plasma concentrations of several proteins, with the strongest association observed with CD209 in several proteomic datasets. We demonstrated experimentally that CD209 directly interacts with the spike protein of SARS-CoV-2, suggesting a mechanism that could explain the ABO association with COVID-19. Our work provides a prioritised list of host targets potentially exploited by SARS-CoV-2 and is a precursor for further research on CD209 and FAS as therapeutically tractable targets for COVID-19.Competing Interest StatementJM and ESEM are full-time employees of Bristol-Myers Squibb.Funding StatementMAK, JSc, JH, AB, DO, MC, EMM, MG, ID were funded by Open Targets. J.Z. and T.R.G were funded by the UK Medical Research Council Integrative Epidemiology Unit (MC_UU_00011/4). JSh and GJW were funded by the Wellcome Trust Grant 206194.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Open TargetsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary data used for genetic analyses are publicly available (Sun et al can be downloaded from GWAS catalog https://www.ebi.ac.uk/gwas/downloads/summary-statistics and COVID-19 HGI summary statistics can be downloaded from their website https://www.covid19hg.org/results/). Data generated from our study are provided in the supplementary tables (pan-MR and cis-MR association results filtered at p < 0.05 and no filters applied to colocalisation results). https://www.ebi.ac.uk/gwas/downloads/summary-statistics https://www.covid19hg.org/results/